Literature DB >> 6788428

The relative amounts of the collagen chains alpha 1(I), alpha 2 and alpha 1(III) in the skin of 31 patients with osteogenesis imperfecta.

M J Francis, K J Williams, B C Sykes, R Smith.   

Abstract

1. The relative amounts of type III and type I collagen, determined as the ratio of their constituent alpha 1(III) and alpha 1(I) chains, have been measured by interrupted electrophoresis of pepsin extracts of skin collagen from 31 patients with osteogenesis imperfecta of varying severity, and from six clinically unaffected family members. In 18 patients the ratio of the alpha 1(I) to alpha 2 chains of type I collagen has also been measured. 2. In the 15 patients with osteogenesis imperfecta classified as mild or the 18 with type I disease the ratio alpha 1(III)/alpha 1(I) was significantly increased (P less than 0.001) and the ratio alpha 1(I)/alpha 2 significantly decreased (P less than 0.005) compared with age-matched control subjects. 3. In three infants with lethal (type II) osteogenesis imperfecta the ratio alpha 1(III)/alpha 1(I) was normal, contrasting with the high ratio observed by others in fibroblast cultures from some apparently similar patients. 4. The ratio of alpha 1(I)/alpha 2 and of alpha 1(III)/alpha 2(I) was increased in both clinically normal parents of a child with severe disease, and in the mother of two children with osteogenesis imperfecta (one lethal and one severe) the ratio alpha 1(III)/alpha 1(I) was increased. 5. In the remaining patients with severe bone deformity (types III and IV) the relative amounts of the different collagen chains varied. 6. These data support previous suggestions that mild or type I osteogenesis imperfecta results from a generalized inability to form sufficient type I collagen, the predominant collagen of adult bone, and imply that in many cases this may result from defective production of the alpha 1(I) chain rather than of the alpha 2 chain. Some patients with severe disease demonstrate a similar defect; but in the remainder other abnormalities of collagen or connective tissue maturation are presumably involved.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6788428     DOI: 10.1042/cs0600617

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  8 in total

1.  Heterogeneity of osteogenesis imperfecta. Biochemical and morphological findings in a case of type III according to Sillence.

Authors:  H Stöss; B F Pontz; H J Pesch; R Ott
Journal:  Eur J Pediatr       Date:  1986-04       Impact factor: 3.183

2.  Osteogenesis imperfecta 1984.

Authors:  R Smith
Journal:  Br Med J (Clin Res Ed)       Date:  1984-08-18

3.  Compositional analysis of collagen from patients with diverse forms of osteogenesis imperfecta.

Authors:  E Kirsch; T Krieg; A Nerlich; K Remberger; P Meinecke; D Kunze; P K Müller
Journal:  Calcif Tissue Int       Date:  1987-07       Impact factor: 4.333

4.  Mutations linked to the pro alpha 2(I) collagen gene are responsible for several cases of osteogenesis imperfecta type I.

Authors:  G Wallis; P Beighton; C Boyd; C G Mathew
Journal:  J Med Genet       Date:  1986-10       Impact factor: 6.318

5.  Heterogeneity of osteogenesis imperfecta type I.

Authors:  C R Paterson; S McAllion; R Miller
Journal:  J Med Genet       Date:  1983-06       Impact factor: 6.318

6.  Histological investigation of skin biopsies in otosclerosis and osteogenesis imperfecta.

Authors:  U Pedersen; H Søgaard; O Elbrønd
Journal:  Arch Otorhinolaryngol       Date:  1984

7.  Vertebral bone mineral content in osteogenesis imperfecta.

Authors:  D Kurtz; K Morrish; J Shapiro
Journal:  Calcif Tissue Int       Date:  1985-01       Impact factor: 4.333

8.  Variations in the serum concentration and urine excretion of alpha 2HS-glycoprotein, a bone-related protein, in normal individuals and in patients with osteogenesis imperfecta.

Authors:  I R Dickson; M Bagga; C R Paterson
Journal:  Calcif Tissue Int       Date:  1983       Impact factor: 4.333

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.